Short-chain fatty acids (SCFAs) are metabolic byproducts of dietary fiber fermentation by gut microbiota, primarily consisting of butyrate, propionate, and acetate. These three SCFAs play a critical role in gut health and systemic metabolism, serving as a "metabolic bridge" between the gut microbiome and host well-being.
Butyrate is the primary energy source for colonocytes, supplying 60-70% of their energy needs. It exerts multiple physiological effects by activating G protein-coupled receptors (GPR41/43) and inhibiting histone deacetylases (HDAC): enhancing tight junction protein expression (to repair intestinal leakiness), promoting regulatory T cell (Treg) differentiation (for immune tolerance), suppressing the NF-κB pathway (anti-inflammatory action), and inducing apoptosis in colon cancer cells.
Propionate is primarily metabolized in the liver, where it inhibits cholesterol synthesis, regulates gluconeogenesis, and promotes GLP-1 secretion (improving insulin sensitivity). Acetate enters peripheral circulation to participate in lipid metabolism and appetite regulation. The synergistic effects of these three SCFAs position the gut microbiota as a key regulator of systemic metabolic health.
In functional medicine product development, there are two pathways to elevate SCFA levels: 1) supplementing prebiotics (FOS, GOS, resistant dextrin) to nourish SCFA-producing bacteria (e.g., Faecalibacterium prausnitzii, Roseburia); or 2) directly supplementing SCFA precursors (Tributyrin, Sodium Butyrate). Hong Kong Dynas Group Co., Ltd. offers prebiotic blends and butyrate precursor products in the GI Support Series, with custom capsule and powder formulations available.
